Migraine sufferers who use Relpax may want to check their medicine cabinets.
Pfizer Inc., the manufacturer of the medication, along with the Food and Drug Administration have announced a recall of the treatment due to potential microbiological contamination.
Two lots of 40 mg tablet packages could have Genus Pseudomonas or Burkholderia contamination and are labeled AR5407 and C4565.
If you take the medication and it is contaminated with the microorganisms, the bacteria could enter the bloodstream and could result in serious, life-threatening infections, the FDA said.
There is also a risk of gastrointestinal distress without a serious infection, but that discomfort is temporary, the FDA said.
© 2020 Cox Media Group